| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/04/2007 | CN1939291A Hydroxyphenyl sulfonated calcium slow-releasing preparation |
| 04/04/2007 | CN1939289A Allicin dropping balls and preparation thereof |
| 04/04/2007 | CN1939287A Puvatadin dropping balls and production thereof |
| 04/04/2007 | CN1939286A Atrovatadin dropping balls and production thereof |
| 04/04/2007 | CN1939284A Valsartan hydrochlorothiazide dropping balls and production thereof |
| 04/04/2007 | CN1939283A Chlorochatain hydrochlorothiazide dropping balls and production thereof |
| 04/04/2007 | CN1939282A Amlodipine benesanli dropping balls and production thereof |
| 04/04/2007 | CN1939279A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/04/2007 | CN1939278A Methods for providing oxidatively stable ophthalmic compositions |
| 04/04/2007 | CN1939277A Methods for stabilizing ophthalmic compositions |
| 04/04/2007 | CN1308375C Lipid-polymer-conjugates compsns. |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308307C Pseudopolymorphic forms of carvedilol |
| 04/04/2007 | CN1308039C Multifunction biocompatible hydrogel and preparation method thereof |
| 04/04/2007 | CN1308034C Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid |
| 04/04/2007 | CN1307998C Novel method and compositions for local treatment of Meniere's disease, tinnitus and hearing loss |
| 04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/04/2007 | CA2521272A1 Capsules comprising topiramate |
| 04/03/2007 | US7199223 Water soluble polyoxyethylene glylcol polyvinylpyrrolidone, polyvinyl alcohol, polyoxazoline, and/or polyacryloylmorpholine, conjugated to antihemophilic factor |
| 04/03/2007 | US7199218 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2007 | US7199151 DHA-pharmaceutical agent conjugates of taxanes |
| 04/03/2007 | US7199111 Aqueous ifosfamide compositions for parenteral administration and a process for their preparations |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7198949 Compositions and methods for altering the biodistribution of biological agents |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198800 spray on skin patch drug delivery system; substantially water insoluble film forming agent; film plasticiser agent; water soluble compound; and organic solvent |
| 04/03/2007 | US7198796 Antifungal parenteral products |
| 04/03/2007 | US7198787 Preferentially kill mammary gland cancer cells; obtain cells, exposed to mixture of toxins, monitor cellular response to toxins |
| 04/03/2007 | US7198779 Compositions for the relief of xerostomia and the treatment of associated disorders |
| 04/03/2007 | US7198777 Optical contrast agents for optically modifying incident radiation |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2417279C Treatment of hyperproliferative skin disorders and diseases |
| 04/03/2007 | CA2385890C Controlled release compositions comprising nimesulide |
| 04/03/2007 | CA2341024C Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| 04/03/2007 | CA2206782C Aerosol drug formulations |
| 04/03/2007 | CA2183430C Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 04/03/2007 | CA2134082C Bioadhesive microspheres and their use as drug delivery and imaging systems |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 04/03/2007 | CA2066384C Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparation and a coating composition |
| 04/03/2007 | CA2065603C Stabilized vitamin d preparation |
| 03/30/2007 | CA2561694A1 Methods for stabilizing ophthalmic compositions |
| 03/29/2007 | WO2007035911A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 03/29/2007 | WO2007035612A2 Polyphenol conjugates as rgd-binding compounds and methods of use |
| 03/29/2007 | WO2007035117A1 Oral vehicle for systemic pharmaceuticals |
| 03/29/2007 | WO2007034736A1 Adhesive skin patch |
| 03/29/2007 | WO2007034586A1 Photocatalytic titanium dioxide microparticle, dispersion liquid thereof and process for producing the same |
| 03/29/2007 | WO2007034495A2 Dextran and arabinogalactan conjugates of therapeutically active compounds |
| 03/29/2007 | WO2007034479A2 Nanoparticles for targeted delivery of active agents |
| 03/29/2007 | WO2007034022A1 Composition for administration to mammals or humans |
| 03/29/2007 | WO2007033654A1 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids |
| 03/29/2007 | WO2007033522A1 Capsule formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007033515A1 Oral formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007033434A1 Fulvestrant formulation |
| 03/29/2007 | WO2007014352A3 Antiviral phosphonate conjugates for inhibition of hiv |
| 03/29/2007 | WO2007012837A3 Compositions for treating psychiatric conditions |
| 03/29/2007 | WO2007000163A8 Immobilisation of polypeptides by irradiation |
| 03/29/2007 | WO2006105993A3 Method for shielding functional sites or epitopes on proteins |
| 03/29/2007 | WO2006102964A3 Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| 03/29/2007 | WO2006096491A3 Anti-ctla-4 antibody compositions |
| 03/29/2007 | WO2006044771A3 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 03/29/2007 | WO2006009682A3 Glue compositions for lung volume reduction |
| 03/29/2007 | WO2005097211A3 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 03/29/2007 | WO2005087199A8 Stabilised supersaturated solid solutions of steroidal drugs |
| 03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
| 03/29/2007 | WO2004043399A3 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 03/29/2007 | WO2002056916A8 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072800 Conjugates for cancer therapy and diagnosis |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070072171 Solid surface for biomolecule delivery and high-throughput assay |
| 03/29/2007 | US20070071841 Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | US20070071823 complexing amphoteric polymers with polynucleotides and delivering the complex into cells |
| 03/29/2007 | US20070071822 Film coated tablet for improved upper gastrointestinal tract safety |
| 03/29/2007 | US20070071820 Delayed release pharmaceutical formulations |
| 03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 03/29/2007 | US20070071810 Additive for tablets |
| 03/29/2007 | US20070071803 Dermal penetration enhancers and drug delivery systems involving same |
| 03/29/2007 | US20070071794 Drugs for treating diabetes |
| 03/29/2007 | US20070071793 Cure for prostate enlargement frequency of urination and cancer |
| 03/29/2007 | US20070071787 Composite material comprising a porous semiconductor impregnated with an organic substance |
| 03/29/2007 | US20070071711 Formulations for topical delivery of bioactive substances and methods for their use |
| 03/29/2007 | US20070071688 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
| 03/29/2007 | US20070071687 Intranasal benzodiazepine compositions |
| 03/29/2007 | US20070071685 Gas-filled microvesicle assembly for contrast imaging |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | DE60119337T2 Aseptische mittel Aseptic medium |
| 03/29/2007 | DE10207394B4 Geschmacksmaskierte oblatenförmige Arzneizubereitung A taste masked pharmaceutical preparation wafer-shaped |
| 03/29/2007 | DE102005046258A1 Immunosorbent for treating insulin resistance or metabolic syndrome comprises a polymeric support to which are attached ligands that specifically bind to interleukin-6 |
| 03/29/2007 | CA2713219A1 Oral vehicle for systemic pharmaceuticals |
| 03/29/2007 | CA2625426A1 Dextran and arabinogalactan conjugates of therapeutically active compounds |
| 03/29/2007 | CA2623576A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 03/29/2007 | CA2623529A1 Pdgf amphiphilic polymer complex |
| 03/29/2007 | CA2623345A1 Fulvestrant formulation |
| 03/29/2007 | CA2623293A1 Nanoparticles for targeted delivery of active agents |